Evidence map›Paper›PMID 27029303›Full record

ArticleAntibiotics (Basel, Switzerland)2013

The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori.

Ilaria M Saracino, Cristina Zaccaro, Giovanna Lo Re, Dino Vaira, John Holton

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ilaria M SaracinoFirst Medical Clinic, University of Bologna, Bologna 40121, Italy. iliaria.saracino@unibo.it.
Cristina ZaccaroFirst Medical Clinic, University of Bologna, Bologna 40121, Italy. crysette@hotmail.it.
Giovanna Lo ReFirst Medical Clinic, University of Bologna, Bologna 40121, Italy. giovanna.lore@studio.unibo.it.
Dino VairaFirst Medical Clinic, University of Bologna, Bologna 40121, Italy. beradino.vaira@unibo.it.
John HoltonDepartment of Health & Social Sciences, University of Middlesex, NW4 4Bt London, UK. john.holton@nhs.net.
University of Bologna · ITMiddlesex University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the effects of two novel copper-based inorganic formulations for their activity against 60 isolates of Helicobacter pylori (Hp). The two copper-based formulations were tested against three NCTC Helicobacter pylori isolates and 57 clinical strains isolated from the UK and Italy in time-kill assays. Both copper-based formulations were bio-cidal against all Helicobacter pylori strains tested reducing the viable count by 4-5 log within 2 h. These two copper-based anti-microbial agents deserve further study in relation to the treatment of H. pylori-related gastric disease.

Indexed as

bactericidalcopperhelicobacternovel formulation

Identifiers

PMID27029303
PMCPMC4790339
OpenAlexW1994848249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.